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Abstract: The advent of next-generation sequencing technologies has not only accelerated findings on various novel non-coding RNA (ncRNA)
species but also led to the revision of the biological significance and versatility of fundamental RNA species with canonical function, such as transfer
RNAs (tRNAs). Although tRNAs are best known as adapter components of translational machinery, recent studies suggest that tRNAs are not always end
products but can further serve as a source for short ncRNAs. In many organisms, various tRNA-derived ncRNA species are produced from mature tRNAs
or their precursor transcripts as functional molecules involved in various biological processes beyond translation. In this review, we focus on the tRNAderived ncRNAs associated with Argonaute proteins and summarize recent studies on their conceivable biogenesis factors and on their emerging roles in
gene expression regulation as regulatory RNAs.
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Introduction

The advent of next-generation sequencing (NGS) technologies
has unveiled the entire picture of the cellular transcriptome,
wherein various non-coding RNA (ncRNA) are widely
expressed from a large part of the genome.1,2 The functional
significance of ncRNAs is particularly evident for the short
20- to 31-nucleotide (nt) ncRNAs bound to the family of
Argonaute proteins.3–5 MicroRNAs (miRNAs), the beststudied class of such RNAs, are approximately 22 nt in length
and posttranscriptionally regulate the expression of complementary target mRNAs. While nearly 2,800 species of human
miRNAs are currently annotated in the miRBase database,6
computational analyses of massive RNA-sequencing (RNASeq) data has kept increasing the number of miRNA species.7,8 miRNAs are estimated to regulate the expression of
most protein-coding genes,9 and a wide variety of other short
and long functional ncRNA species coexist in the cellular
transcriptome,10,11 exhibiting a tremendous impact of ncRNAorchestrated regulatory mechanisms on normal developmental and physiological processes and diseases.12,13 NGS studies
have accelerated findings on not only novel ncRNA repertoires
but also well-characterized fundamental RNA species with
canonical functions, such as transfer RNAs (tRNAs), which
stimulated us to revisit their significance and versatility.
tRNAs are 70- to 90-nt ncRNAs that fold into a cloverleaf
secondary structure and L-shaped tertiary structure. Since
their discovery in the 1950s, tRNAs have been best known as

fundamental adapter components of translational machinery,
where they translate codons in mRNA into amino acids in
protein.14 The human genome encodes .500 tRNA genes,15
along with numerous tRNA-lookalikes resembling nuclear
and mitochondrial tRNAs.16,17 The multitude of tRNA genes
in the genome, along with high stability,18 places tRNAs
among the most abundant RNA molecules in the cellular
transcriptome. Because of their abundance and well-defined
role in translation, RNA fragments derived from tRNAs,
found in early NGS studies, were often disregarded as nonfunctional degradation products. However, recent biochemical and bioinformatic evidence has generated a previously
unsuspected concept that tRNAs are not always end products
but are further able to serve as a source for short ncRNAs.
In many organisms, specific tRNA-derived ncRNAs are produced from mature tRNAs or their precursor transcripts, not
as random degradation products, but as functional molecules
involved in many biological processes beyond translation.19–23
tRNA-derived ncRNAs identified to date can be classified
into two groups: tRNA halves and tRNA-derived fragments
(tRFs).19–23 tRNA halves are composed of 30–35 nt fragments
derived from either the 5′- or the 3′-part of mature tRNAs.
tRFs are shorter than tRNA halves, ranging from 13 to 32 nt
in length and are currently subclassified into four subgroups:
5′-tRFs, 3′-CCA tRFs, 3′-U tRFs, and 5′-leader-exon tRFs. The
5′-tRFs and 3′-CCA tRFs correspond to the 5′- and 3′-parts of
mature tRNAs containing processed mature 5′- and 3′-CCA
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expressed in numerous tissues, and four of the PIWI clade,
whose expressions are restricted to the germline.3–5 All
four AGO members associate with miRNAs to form effector complexes for their posttranscriptional regulatory roles,
while only AGO2 shows endonucleolytic cleavage activity of
target mRNAs. Biochemical purification and identification
of miRNAs and their target mRNAs have been accompli
shed by purifying AGO proteins using immunoprecipitation
(AGO-IP) followed by investigation of the AGO-bound RNAs
in the IP fraction.24,25 Similar sizes of tRFs with miRNAs
allowed researchers to reason that tRFs may be AGO-bound
RNA species. Although early studies have already observed
tRNA-derived sequences from AGO-IP fraction, as described
below, more recent reports have demonstrated an evident association of the tRNA-derived ncRNAs with AGO proteins.
Hereafter, we will use tRF amino acid/anticodon to denote a tRF

termini, respectively (Fig. 1). The 3′-U tRFs are derived from
the 3′-leader sequence of precursor tRNAs (pre-tRNAs) that
harbor 3′-terminal uridine stretches, which result from transcriptional termination by RNA polymerase III at thymidine
tracts (Fig. 1). The 5′-leader-exon tRFs include the 5′-leader
sequence of pre-tRNAs and the 5′-part of mature tRNAs.
Although several excellent reviews have already described the
repertoire, biogenesis, and functional significance of each class
of the tRNA-derived ncRNAs,19–23 in this review, we particularly focus on the tRFs bound to Argonaute proteins and
summarize their conceivable biogenesis factors and emerging
roles in gene expression regulation as miRNAs.

tRFs Associated with AGO Proteins

In humans, the Argonaute protein family has eight members:
four of the AGO clade (AGO1–4), which are ubiquitously
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Figure 1. Schematic representation of the biogenesis of miRNAs and tRFs associated with AGO proteins.
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derived from the tRNA corresponding to the amino acid and
anticodon sequences.
The first focused detection of AGO-bound tRNAderived ncRNAs in humans was reported in 2009. 26 Cole
et al. identified numerous tRFs in RNA-Seq data from
HeLa cells. 26 Majority of the identified tRFs were 5′-tRFs,
and 5′-tRFGlnCUG, selected for the analyses, was shown to be
present in AGO1- and AGO2-IP fractions. This result suggests the loading of the tRF in both of the AGO proteins,
although 5′-tRFGlnCUG was also found in the fraction where
AGO proteins were absent and therefore it seems that not all
tRFs are loaded onto the AGO proteins. Haussecker et al.
detected 3′-CCA tRFs and 3′-U tRFs in Human Embryonic
Kidney 293 (HEK293) cells by northern blots. 27 Interestingly, the identified tRF was selectively loaded onto different AGO proteins; 3′-U tRFSerUGA was found to be loaded
onto AGO3 and AGO4 but not to AGO1 and AGO2. 27
Burroughs and Ando et al. performed AGO1-3 IPs using
THP-1 cells followed by NGS of the RNA contents of the
IP fractions, and identified several 5’-tRFs that were specifically loaded onto AGO1, but slightly or not at all onto AGO2
and AGO3. 28,29 They also observed the presence of 3′-CCA
tRFs in their AGO-bound RNA libraries. Li et al. identified numerous 5′-tRFs and 3′-CCA tRFs in RNA-Seq libraries from BCP1 and HEK293 cells and demonstrated that
both of the selected tRFs, 3′-CCA tRF HisGUG and 3′-CCA
tRFLeuCAG, were loaded onto AGO2 but not onto AGO1.30
Maute et al. focused on 3′-CCA tRFGlyGCC whose expression levels are regulated by differentiation stages in mature
B cells. 31 The tRF was enriched in the AGO4-IP fraction,
followed by fractions from AGO1- and AGO3-IPs, but less
enriched in the AGO2-IP fraction. Kumar et al. analyzed
many available short RNA libraries and observed numerous
5′-tRFs, 3′-CCA tRFs, and 3′-U tRFs, whose expression profiles varied in different cell lines and tissues. 32 Their analyses
of HEK293 AGO-IP fractions obtained from Photoactivatable-Ribonucleoside-Enhanced Crosslinking and Immunoprecipitation (PAR-CLIP)33 suggested that 5′-tRFs and
3′-CCA tRFs associate with AGO1, AGO3, and AGO4, but
not with AGO2, 32 whereas 3′-U tRFs were absent in all four
AGO-IP fractions. Positional analyses of crosslink-induced
mutations in PAR-CLIP data indicated that tRFs were
loaded onto AGO proteins in a manner similar to miRNAs. 32
Taken together, it could be concluded that the attempts to
connect tRFs, at least partially, with the miRNA pathway
have been successful. As miRNAs, some tRF species of the
three classes (5′-tRFs, 3′-CCA tRFs, and 3′-U tRFs) are the
interacting partners of AGO proteins.
The presence of tRFs in the AGO-IP fraction has also
been reported for many other organisms such as mouse, 34
Drosophila, 35 and Bombyx,36 as well as in plant.37 Along the
same lines, PIWI proteins, the other Argonaute family subclade that associates with PIWI-interacting RNAs (piRNAs) for germline development, 3–5 have also been reported

to interact with tRNA-derived ncRNAs in various organisms
such as human, 38 marmoset, 39 Drosophila,40 Trypanosoma,41
and Tetrahymena.42,43 Functional significance of the PIWIbound tRFs in RNA metabolism has been shown in Tetrahymena.43 These findings suggest that tRNA-derived ncRNAs
are widely-conserved functional factors across phyla that
interact with Argonaute family proteins.

Biogenesis Factors for AGO-Bound tRFs

Asymmetric loading of tRFs onto the different AGO proteins could be due to coupling of tRF biogenesis with AGO
loading mechanism and/or preferences of the AGO proteins and other biogenesis factors for the particular structures of tRFs or their precursors, namely mature tRNAs
and pre-tRNAs. Mature tRNAs are produced from pretRNAs, which undergo several maturation steps44 (Fig. 1).
Pre-tRNAs are first transcribed by RNA polymerase III,
and their 5′-leader and 3′-trailer sequences are removed by
endonucleolytic cleavage of RNase P and RNase Z, respectively. The “CCA” trinucleotides are then attached to the
3′-termini by a CCA-adding enzyme, and various different
non-canonical base modifications are attached by modification
enzymes. The resultant mature tRNAs are finally aminoacy
lated by their cognate aminoacyl-tRNA synthetases. Judging
from the regions and sequences that the tRFs originate from,
both pre-tRNAs and mature tRNAs must serve as substrates
for the production of tRFs.
In vertebrates, canonical miRNA biogenesis (Fig. 1)
starts from transcription of the miRNA gene by RNA polymerase II to generate a primary transcript (pri-miRNA),
which is subsequently cleaved by Drosha, an endonuclease
belonging to the RNase III superfamily, forming a complex
with DGCR8.3–5 The resultant ∼70-nt precursor miRNA
(pre-miRNA) with a hairpin-shaped structure is further processed by Dicer, another RNase III endonuclease, leading to
the production of RNA duplex, one strand of which is then
loaded onto AGO proteins.3–5 Considering the expression of
tRFs complexed with AGO proteins, one may infer Drosha
and Dicer endonucleases are involved in the production of
such AGO-loaded tRFs. Indeed, the biogenesis of some tRFs
belonging to 5′-tRFs, 3′-CCA tRFs, or 3′-U tRFs have been
reported to be dependent on Dicer in humans, 26,27,31 mice,45
and Drosophila35 (Fig. 1). Furthermore, Dicer is also reported
to cleave tRNAGlnCUG to generate 5′-tRFGlnCUG in vitro.26
Although the cloverleaf secondary structure of tRNAs does
not meet the criteria for canonical Dicer substrates, some precursor and mature tRNA molecules may alternatively form a
long hairpin structure, particularly before modifications are
attached, which may make tRNA structures suitable for Dicer
processing as predicted in the case of mice tRNA IluUAU.45
Some tRFs seem to be generated via Dicer-independent
biogenesis mechanism.27,32 Because several non-canonical
miRNA biogenesis pathways are independent of Drosha or
Dicer and utilize precursor RNAs forming various structures
Gene Regulation and Systems Biology 2015:9
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other than canonical hairpin-loop structures, such as singlestranded RNAs, AGO-bound tRFs may be produced through
such non-canonical pathways.46,47 Alternatively, the other
enzymes, which are not involved in miRNA biogenesis
would be involved in the production of AGO-bound tRFs.
RNase Z cleavage has been shown to produce 3′-U tRFs from
pre-tRNAs in a Dicer-independent manner.27,48 Moreover,
Angiogenin (ANG), a member of the RNase A superfamily,
is the candidate enzyme responsible for AGO-bound tRFs. In
mammalian cells, ANG was first discovered to be the enzyme
that cleaves the anticodon loops of mature tRNAs to produce
tRNA halves upon stress stimuli.49,50 However, it has also
been shown that ANG is able to cleave the T-loop of tRNAs
to produce 3′-CCA tRFLysUUU in vitro (Fig. 1), 30 although this
has yet to be confirmed in vivo.
It remains to be elucidated how the biogenesis factors
are able to access and process the rigid structure of mature
tRNAs, because, in the cytoplasm, mature aminoacylated
tRNAs form an L-shaped tertiary structure and are tightly
bound by an elongation factor to be transported to the
ribosome. Because tRFs and tRNA halves coexist (e.g.,
5′-tRFs were purified together with 5′-tRNA halves in
Dicer-immunoprecipitates), 36,51–54 the tRNA halves may be
direct precursors of tRFs in some instances. Because the
anticodon loop is exposed and accessible in animoacylated
tRNA–elongation factor complexes, mature tRNAs may
first be subjected to anticodon cleavage by ANG or other
nucleases and then the generated tRNA halves dissociated from an elongation factor may be further processed
for the production of tRFs. Further analyses are required
to fully unveil the biogenesis factors and mechanisms for
AGO-bound tRFs.

Functional Significance of AGO-Bound tRFs Acting
as miRNAs.

miRNAs deposit AGO proteins onto target RNAs by recognizing complementary sequences generally located in
their 3′-UTR.3–5 Imperfect miRNA base-pairing with target
mRNAs appears to induce translational silencing, whereas
extensive base-pairing triggers exonucleolytic decay of the
target mRNAs. Considering their association with AGO
proteins and their similar size to miRNAs, it is not surprising that AGO-bound tRFs act as miRNAs and silence the
expression of their complementary target mRNAs.
Research on viruses has shown the first demonstration
of AGO-bound tRFs functioning as miRNAs. It has long
been known that retroviruses use host tRNA as a primer
for reverse transcription during the first step of retroviral
replication. The 3′-part of such tRNAs is complementary and
binds to the primer-binding site (PBS) of the virus sequence.
In human MT4 T-cells infected with human immunodeficiency virus type 1 (HIV-1), Yeung et al. observed the
abundant expression of an 18-nt 3′-CCA tRF LysUUU which
is complementary to the PBS of HIV-1.55 Moreover, the
30
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3′-CCA tRF LysUUU was loaded onto AGO2 and induced
AGO2-mediated cleavage of the PBS, thereby silencing
PBS-containing reporter gene and a HIV-1 gene. These
results suggest important roles of AGO-loaded tRFs on
repression of virus replication. Because the human genome
contains many endogenous retroviral sequences and 3′-tRFs
are highly complementary to these, 30 tRF-directed pathways
may also play ubiquitous roles in silencing endogenous viral
elements. As another example of the involvement of tRFs
in viral expression, Wang et al. reported that infection with
human respiratory syncytial virus (RSV) led to accumulation
of 5′-tRFs derived from various cytoplasmic tRNAs.56 One
chosen 5′-tRF, 5′-tRF GluCUC, was shown to be generated by
ANG-mediated cleavage at sites adjacent to the 5′-end of
the anticodon loop. Because the 5′-tRF GluCUC showed activity in repressing complementary reporter gene expression,
it is highly plausible that the tRF is loaded onto the AGO
proteins. The tRF was further shown to have functional significance in regulating RSV replication.56
In addition to the viral research, Maute et al. reported
a tRF functioning as miRNA in mature human B cells.31
A 22-nt AGO-bound 3′-CCA tRFGlyGCC showed activity in
repressing the expression of target mRNAs in a sequence-specific manner. RPA1, an essential gene for DNA dynamics and
repair, was identified as one of the endogenous targets containing complementary sequences of the tRF in its 3′-UTR. Stable
expression of the tRF suppressed cell proliferation and modulated the response to DNA damage in an RPA1-dependent
manner, indicating the clear biological importance of 3′-CCA
tRFGlyGCC.31 Haussecker et al. used a reporter assay to confirm that AGO-bound 3′-CCA tRFs and 3′-U tRFs repressed
complementary target RNAs.27 These results suggested that
the tRFs were able to function as miRNAs, although further
identification of endogenous tRF targets using CLIP25,33 and
degradome RNA analysis57 will be required to fully understand their biological significance. One of the tRFs used in
their analysis, a 3′-U tRFSerUGA, was reported to promote cell
proliferation in the other study by Lee et al.48, validating that
at least this tRF has an important cellular role. In addition
to their roles in translational repression in the cytoplasm,
AGO proteins have been reported to play distinct roles in the
nucleus, such as modulation of histone methylation, mRNA
splicing, and DNA damage repair, which is guided by miRNAs.58,59 AGO-bound tRFs may be involved in such nuclear
functions of AGO proteins. Accumulation of further evidence
of the functionality and endogenous biological roles of AGObound tRFs would lead to clearcut designation of these tRFs
as regulatory RNA molecules.

Perspectives

The number of reports characterizing expression and function of tRNA-derived ncRNAs has been growing, which
enforces the conceptual consensus that cells utilize mature
and precursor tRNAs as a source for short, functional
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ncRNAs. Although this review detailed Argonaute-bound
tRFs, there are various other classes of tRNA-derived
ncRNAs that are functional through mechanisms without involvement of Argonaute proteins. A representative
example is the tRNA halves, termed tRNA-derived stressinduced RNAs (tiRNAs),49 whose production through ANG
cleavage of the tRNA anticodon are triggered by various
stress stimuli.19–23 tiRNAs promote the stress response by
stress granule formation60 and global inhibition of translation by YB-1-involved pathway,49,61,62 thereby associating
with normal biological processes and diseases.19–23,52 As
another example of functional tRNA halves, sex hormonedependent tRNA-derived RNAs (SHOT-RNAs) have been
recently identified in breast and prostate cancers.63 SHOTRNAs are also produced by ANG cleavage of the tRNA
anticodon, which is promoted by sex hormones and their
receptors, and these enhance cell proliferation.63
Despite the findings described in this review, information regarding expression profiles, biogenesis pathways, and
biological meanings of AGO-bound tRFs is still fragmented.
One of the obstacles for comprehensive identification of the
tRFs would be the extensive presence of posttranscriptional
modifications in tRNAs. Over 100 posttranscriptional modifications are present in tRNAs, many of which play crucial
roles in tRNA folding and function such as codon recognition.64–67 Because it is highly plausible that many tRNAderived ncRNAs are produced from modified tRNAs and
because many modifications inhibit Watson–Crick base paring and thus arrest reverse transcription,68 heavily modified
tRNA-derived ncRNAs would not be accurately captured by
RT-PCR based sequencing methods. Modifications would
also influence the biogenesis and function of tRNA-derived
ncRNAs. For example, the presence of base-pairing-inhibitory modification inside the AGO-bound tRF would affect
the efficiency of targeting and regulation of mRNAs. These
points based on tRNA biological properties should be borne
in mind for analyses of tRNA-derived ncRNAs.
As another considerable point, analyses of tRNAs and
their fragments should be executed by proper bioinformatics.
Genomes encode many identical tRNA genes and their slightly
different variants, and identical tRNA fragment sequences
can be present in non-tRNA regions in the genome.69 Very
recently, during revising this manuscript, exhaustive analyses of massive RNA-Seq data have newly identified the fifth
class of tRF, i-tRFs, which are wholly derived from internal regions of mature tRNAs and are loaded onto AGO
proteins.70 tRFs including i-tRFs were reported to be differentially expressed in different cell types, tissues, disease
states and human race.70 As in the effort to generate a tRNA
fragment database by Kumar et al.71, cataloging the expression
of tRNA fragments in various cell types and tissues, which
should be based on appropriate bioinformatics approach and
uniform nomenclatures will accelerate future investigations of
tRNA-derived ncRNAs.

It is not known why the cells utilize tRNAs for ncRNA
production. One potential answer may be the regulatory mechanism of tRNA abundance and heterogeneity. tRNA abundance
varies greatly among different human cells and tissues, and
the translational regulation by tRNA heterogeneity has been
suggested.72–74 The expression of tRNA halves is also variable
in different cells and tissues and further regulated by tRNA
modification states, various stressors, and hormones.19–23,63 The
uniquely regulated mechanism in controlling the quality and
quantity of tRNAs and tRNA halves may consequently result
in the opportunity for cells to generate, from these precursor
RNAs, specific class of ncRNAs whose species and abundance would then also be uniquely controlled. In that regards,
as shown in the case of various types of ncRNAs,11 tRNAderived ncRNAs may emerge as a source of biomarkers and
targets for therapeutics. Indeed, use of tRNA-derived ncRNAs
as indicators for biological states has been suggested.63,70,75,76
Research on tRNA-derived ncRNAs is still in the initial stage
and their biological functions may extend beyond our expectations. Further efforts to understand the expression profiles,
biogenesis, and function of tRNA-derived ncRNAs will
advance our knowledge regarding the expanding tRNA world
and may provide significant insights into the pathophysiology
of diseases.
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